Author:
van Uden Wim,Pras Niesko,Homan Ben,Malingré Theo M.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Issell BF, Rudolph AR & Louie AC (1984) Etoposide (VP-16?213): an overview. In: Issell BF, Muggia FM & Carter SK (Eds) Etoposide (VP-16?213) ? Current Status and New Developments (pp 1?13). Academic Press Inc, Orlando
2. Saito H, Yoshikawa H, Nishimura Y, Kondo S, Takenchi T & Umezawa H (1986) Studies on lignan lactone antitumor agents I. Synthesis of aminoglycosidic lignan variants related to podophyllotoxin. Chem. Pharm. Bull. 34: 3733?3740
3. Saito H, Yoshikawa H, Nishimura Y, Kondo S, Takenchi T & Umezawa H (1986) Studies on lignan lactone antitumor agents II. Synthesis of N-alkylamino- and 2,6-dideoxy-2-aminoglycosidic lignan variants related to podophyllotoxin. Chem. Pharm. Bull. 34: 3741?3746
4. Thurston L, Irie H, Tani S, Han FS, Liu ZC, Cheng YC & Lee KH (1986) Antitumor agents 78. Inhibition of human DNA topoisomerase II by podophyllotoxin and ?-peltatin analogues. J. Med. Chem. 29: 1547?1550
5. Clark PJ & Slevin ML (1987) The clinical pharmacology of etoposide and teniposide. Clin Pharmokinet. 12: 223?252
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献